Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Roche Drops Aleglitazar In Another Cardiology/Metabolics Setback

This article was originally published in The Pink Sheet Daily

Executive Summary

Development of dual PPAR agonist aleglitazar terminated due to fractures, renal impairment and heart failure reported in the AleCardio study, leaving another hole in Roche’s cardiovascular/metabolic pipeline.

Advertisement

Related Content

Roche’s pRED Team Reviews R&D Wish List As Firm Continues Push To Diversify
Bitopertin’s Schizophrenia Failure Stirs Doubt About Roche’s CNS Plans
Dalcetrapib Failure Raises Yet More Questions On Value Of Tinkering With HDL Cholesterol
Glycemic Control Not Enough For New Diabetes Drugs, Roche Exec Says
Roche/Ipsen's Suspended Taspoglutide Could Become Another Diabetes Casualty
With One Foot Firmly Planted In Oncology, Roche Moves The Other Into CV/Metabolic
Lilly Halts Trials Of PPAR Alpha Agonist After Preclinical Safety Signal

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS075946

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel